Financial Toxicity in Cancer Patients Treated with Radiotherapy – a jDEGRO Confirmatory Cross-Sectional Study

Financial Toxicity in Cancer Patients Treated with Radiotherapy – a jDEGRO Confirmatory Cross-Sectional Study - jDEGRO FinTox

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028784

Enrollment

504

Registered

2022-04-11

Start date

2022-06-27

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C80.9

Interventions

Group 1: Anonymous Survey

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: i.) Cancer patient about to complete (+/- 2d) a course of radiotherapy ii.) Ability to understand and complete the questionnaire iii.) > 18 years iv.) Patient gave informed consent

Exclusion criteria

Exclusion criteria: i.) Patient has already participated in the study for another course of radiotherapy

Design outcomes

Primary

Measure	Time frame
• Confirmation of the prevalence of financial toxicity based on a previous study per EORTC QLQ-C30 q28 ("subjective financial distress") and Confirmation of risk factors for financial toxicity based on a previous study	—

Secondary

Measure	Time frame
Exploration of additional variables as risk factors for financial toxicity (e.g. distress, duration of radiotherapy) and Association of financial toxicity and patient satisfaction	—

Countries

Germany

Contacts

Public ContactAlexander Fabian

Klinik für Strahlentherapie

alexander.fabian@uksh.de043150026501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026